Biotech & MedTech News
-
Sixth Wave Innovations Inc. and Magnus Mineral Resources (PVT) Ltd Sign Memorandum of Understanding for Testing IXOS(R) Mining Technology and Implementation at the Penhalonga Gold Mine
August 9, 2022 (Source) – Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) (“Sixth Wave or SIXW or…
-
Zentek Provides Update on Commercial Partnerships
August 5, 2022 (Source) — Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq: ZTEK; TSX-V: ZEN), an intellectual property development and…
-
SIXW: Correction of News Release
August 2, 2022 (Source) – Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) (“Sixth Wave”, “SIXW” or the…
-
Valeo Pharma Closes US$40 Million Non-Dilutive Financing from Sagard Healthcare Partners
Proceeds to fund acquisition of Canadian rights to 3 growing commercial stage drugs Acquisition allows Valeo to expand…
-
Valeo Pharma Enters into License Agreement with Kaléo for the Canadian Rights to ALLERJECT®
700,000 Canadians suffering from severe allergies Canadian epinephrine auto-injector market exceeds $80M annually ALLERJECT peak sales potential expected to…
-
Valeo Pharma Enters into an Agreement for Ophthalmic Products, PrXIIDRA® AND PrSIMBRINZA®, in Canada
Ophthalmology becomes additional strategic therapeutic area Significant market opportunities with more than 6 million1 Canadians suffering from dry eye…
-
Awakn Life Sciences’ Phase III Trial Approved for Approximately CA$2.5 Million Funding from UK State Covering 66% of Costs
Phase III Trial to Cost approximately CA$3.75 million with Awakn’s contribution expected to be approximately CA$1.25 million, Marks…
-
Sixth Wave Updates on Affinity(TM) System Installation Schedule
July 19, 2022 (Source) – Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) (“Sixth Wave”, “SIXW” or the…
-
Zentek Files a Provisional Patent on the use of ZenGUARD(TM) as an Anti-Inflammatory Agent
July 18, 2022 (Source) – Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, has…
-
Awakn Life Sciences Provides a Business and Corporate Update
July 15, 2022 (Source) – Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (‘Awakn’), a revenue-generating biotechnology…
